• 한국약용작물학회지
• /
• 제13권3호
• /
• pp.122-125
• /
• 2005

'조현' 율무는 조숙, 단간, 다수성 품종을 육성하기 위하여 1992년에 박피, 다수성인 수원6호와 조숙, 단간인 오카야마재래종을 교잡한 것을 모본으로 조숙, 다수성인 UCN300-25를 부본으로 한 삼원교배로 $F_1$ (SJ920)을 얻었다. 1993년 하계에 $F_1$을 양성하였고, $1994{\sim}1997$년에는 $F_2{\sim}F_5$를 계통육성하였으며, 1998년과 2001년 하계에 생산력검정을 실시하였다. $2002{\sim}2004$년 3년간 '연천8호가는 계통명을 부여하여 3개 지역에서 지역적응성을 시험하였다. 그 결과 연천8호는 조숙, 단간, 다수성의 특성이 우수하다고 인정되었고, 2004년 12월 직무육성품종 심의위원회에서 중부 및 북부지역에 적합한 품종으로 결정되었으며 '조현'으로 명명되었다. 주요 특성을 요약하면 다음과 같다. 1. 생육초기의 엽초색과 엽신색은 각각 자색과 녹색이며, 출수기의 엽색과 줄기색은 녹색이었다. 암술색은 유백색이고 종피색은 암갈색이었다. 2. 출수기와 성숙기는 표준품종인 율무1호보다 각각 8일, 15일 빨랐다. 간장은 율무1호보다 22 cm 짧았고, 분얼수는 비슷하였다. 천립중은 105 g이었다. 3. 잎마름병과 조명나방 피해에 대한 저항성은 중강으로 율무1호와 비슷하였고, 절간도복에는 약하였다. 4. 수량성은 생산력검정에서 312 kg/10a로 대조품종 율무1호보다 15% 증수되었고,지역적응시험 결과 3개소 평균 320kg/10a로 18% 증수되었다. 5. 정현비율은 60%로 율무1호보다 5% 낮았고, 종피경도는 $4.13\;kg/cm^2$ 이었다.

• 대한본초학회지
• /
• 제36권5호
• /
• pp.109-115
• /
• 2021

Objectives : 'Johyun' yulmoo which is a new variety of Coix lacryma-jobi var. ma-yuen Stapf sprout was developed and registered by Rural development administration in 2004. This variety was derived from the cross between single cross of Suwon-6 and Okayama and UCN300-25 as F1. It is characterized by early maturity, short plant height, a strong resistance, and a superior yield and is suitable for the central and northern regions. Accordingly, we were performed and evaluated single oral dose toxicity test of 'Johyun' yulmoo sprout (JYS) in Sprague-Dawley (SD) rats. Methods : Single oral dose toxicity test was performed using with male and female rats. Rats were divided into two groups: Group 1, vehicle-treated rats (Control); Group 2, JYS 5000 mg/kg-treated rats. JYS was orally administered to male and female rats at dose levels of 5000 mg/kg. Animals were monitored on the mortality, clinical signs, body weight changes, and necropsy findings for 14 days. groups : Group 1, vehicle-treated rats (Control); Group 2, JYS 5000 mg/kg-treated rats. JYS was orally administered to male and female rats at dose levels of 5000 mg/kg. Animals were monitored on the mortality, clinical signs, body weight changes, and necropsy findings for 14 days. Results : After oral treatment of JYS, we could not find any mortality at 5000 mg/kg. Compared with the control group, there were also no significant differences in clinical sign, weight changes, weight gain, and gross abnormalities in JYS 5000 mg/kg-treated group. Conclusions : Taken together, these results suggest that approximate lethal dose of JYS was considered as over 5000 mg/kg. Results from this study provide scientific evidence for the safety of JYS. Moreover, this study could be used as a basis for dose-setting data of the repeated dose 13-week oral toxicity test of JYS.

• 대한예방한의학회지
• /
• 제26권1호
• /
• pp.1-10
• /
• 2022

Objectives : The aim of this study was to introduce the development process of Korean medicine health promotion program for short stature children that is suitable for applied at public health center. Methods : The draft of health promotion program was developed through literature search of previous similar programs and advice of several experts. A small conference targeted public health Korean medicine doctors was also held to introduce the developed program and discuss for improvements. Results : The details of 12-week of Korean medicine health promotion program for children growth are as follows: 4-week of taking herbal medicines (Yukmijihwang-tang or Yukgunja-tang), contactless counseling with Korean medicine doctor, self-care home kit consisting of Sogeonjung-tang tea leaf, Sogeonjung-tang with Cervi Parvum Cornu extract, ear acupressure stick, finger chuna manual, growth diary, and jump rope. Conclusions : This health promotion program can help to increase the height of children and self-esteem of children with short stature as well as decrease the stress of parents.

• Korean Journal of Acupuncture
• /
• 제40권1호
• /
• pp.1-12
• /
• 2023

Objectives : This study aims to provide information regarding the status and quality of mobile applications (MAs) using self-acupressure by performing a systematic review. Methods : We conducted comprehensive searching on five international databases and two app markets from inception to July 31, 2022 to identify MAs using self-acupressure. We analyzed the characteristics of each MA regarding the name of the MA, registered app markets, target symptoms, developers, the year and country of development, cost, target age, media function, and expertise. We assessed the quality of each MA using Mobile Application Rating Scale (MARS). Results : We identified a total of 30 MAs using self-acupressure (25 MAs from the app market and 6 MAs from clinical studies, with 1 MA in common). 17 out of 24 MAs from the app market provided self-acupressure regimens for various symptoms and the others provided regimens for specific symptoms such as memory, anxiety, depression, asthma, allergy, low back pain, and headache. 14 developers were reported. 23 MAs were developed after 2013. The largest number of MAs were developed in the United States. The target age group of 12 MAs was above the age of 3, and that of 11 MAs was above the age of 12. 14 MAs provided multimedia functions such as videos. 13 MAs provided information of expertise. From clinical studies, only 3 out of 6 MAs were accessible through the app market. 4 MAs were developed by the researchers of the study. In terms of MARS, the score of MAs from the app market was higher than that of MAs from clinical studies in both objective and subjective evaluation areas. Conclusions : This study summarizes the characteristics of MAs using self-acupressure. More MAs using self-acupressure should be developed and further clinical research for MA on each symptom and disease is warranted for the diversification of MA fields using self-acupressure.